FDA Authorizes 11 ZYN ULTRA Nicotine-Pouch Products for Philip Morris International
Brighton Jones increased its stake in Philip Morris International by 31.1% in the fourth quarter, while other funds also adjusted holdings. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term move away from combustible tobacco, alongside generally favorable analyst ratings and higher price targets.